Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orchid Chemicals & Pharmaceuticals Ltd.

www.orchidpharma.com

Latest From Orchid Chemicals & Pharmaceuticals Ltd.

Pfizer Pulls Plug On Two Unviable Indian Sites, Over 1,500 Jobs At Risk

Pfizer is ending operations at two Indian manufacturing sites, including one with a checkered regulatory history. Approximately 1,700 jobs are at stake as a result of the action, though the US multinational clarified that it is not making a widespread exit from Indian manufacturing.
Commercial Strategy

Earnings Briefs: Valeant, Vertex, BioMarin, Endo, Hospira

Valeant attributes 14% organic growth in U.S. sales to Bausch + Lomb acquisition, disputing Allergan assertion that the deal has not borne fruit. Vertex sees evidence of sustained benefit for CF patients in Kalydeco long-term usage study. Other updates from the second quarter earnings calls, in brief.

BioPharmaceutical Business Strategies

Is The Non-compete Clause For Cross-border Deals In India A Burden Or A Boost?

Deal makers are cautiously viewing the fallout of a recent government statute to prevent non-compete clauses in cross-border deals for existing Indian companies except in special circumstances. Experts await clarification on the statute but some say the new norm will impede deals and affect valuations.

BioPharmaceutical India

Teva Preserves Azilect’s Patent Even After FDA Rejects Indication

Court rules Mylan failed to prove the Azilect patent is invalid; expert testifies drug is “more likely than not” to slow Parkinson’s disease progression, even if FDA remains unconvinced.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Orchid Chemicals & Pharmaceuticals Ltd.
  • Senior Management
  • K. Raghavendra Rao, Managing Dir.
  • Contact Info
  • Orchid Chemicals & Pharmaceuticals Ltd.
    Phone: (91) 44 28211000
    313, Valluvar Kottam High Rd.
    Nungambakkam
    Channai, 600 034
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register